Temporal Artery Biopsy is not Required in all Cases of Suspected Giant Cell Arteritis

Department of Academic Surgery, Cork University Hospital, Wilton, Cork, Ireland.
Annals of Vascular Surgery (Impact Factor: 1.17). 01/2012; 26(5):649-54. DOI: 10.1016/j.avsg.2011.10.009
Source: PubMed


Temporal artery biopsy (TAB) is performed during the diagnostic workup for giant cell arteritis (GCA), a vasculitis with the potential to cause irreversible blindness or stroke. However, treatment is often started on clinical grounds, and TAB result frequently does not influence patient management. The aim of this study was to assess the need for TAB in cases of suspected GCA.
We performed a retrospective review of 185 TABs performed in our institution from 1990 to 2010. Patients were identified through the Hospital In-Patient Enquiry database and theater records. Clinical findings, erythrocyte sedimentation rate, steroid treatment preoperatively, American College of Rheumatology (ACR) criteria for GCA score, biopsy result, and follow-up were recorded.
Fifty-eight (31.4%) biopsies were positive for GCA. Presence of jaw claudication (P = 0.001), abnormal fundoscopy (P = 0.001), and raised erythrocyte sedimentation rate (P = 0.001) were significantly associated with GCA. The strongest association with positive biopsy was seen with the prebiopsy ACR score (P < 0.001). Twenty-four (13.7%) patients had undergone biopsy, despite no potential for meeting ACR criteria preoperatively. None of these were positive. Overall, 29 (16.4%) patients had management altered by TAB result.
Our results confirm that TAB does not affect management in the majority of patients with suspected GCA. We conclude that TAB has benefit only for patients who score 2 or 3 on the ACR criteria for GCA without biopsy.

65 Reads
  • Source
    • "Several studies evaluating temporal artery biopsies show positive biopsy results in 20–31%. Positive biopsy results are reported to be correlated with higher age and inflammation, higher score on American College of Rheumatology (ACR) criteria and specimen length [23] [26] [27]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In the differential diagnostic process for rheumatic inflammatory and/or connective tissue diseases (CTDs), history taking and physical examination are of main importance, more than additional investigations, as many diagnoses are clinical diagnoses with specific clinical/patterns and gold standards are often lacking. In rheumatic diseases and, especially, CTD, many organ systems apart from the joints may be involved. These include the skin and underlying tissues, muscles, salivary glands, nerves, kidneys and blood vessels. Biopsy specimens of these tissues may be helpful in establishing a diagnosis, in assessing the extent and severity of organ involvement and sometimes in monitoring therapy. In this chapter, practical information is described regarding which clinical practice might indicate a need for biopsy, and on how to prepare the patient, how to perform the biopsy and handle the biopsy specimen. In addition, the limitations and complications one should be cautious of are described. For full details of the clinical spectrum of the diseases and the histopathology, the reader is kindly referred to relevant textbooks.
    Best practice & research. Clinical rheumatology 04/2013; 27(2):209-36. DOI:10.1016/j.berh.2013.03.002 · 2.60 Impact Factor

  • Zhonghua bing li xue za zhi Chinese journal of pathology 09/2012; 41(9):641-4. DOI:10.3760/cma.j.issn.0529-5807.2012.09.019
  • [Show abstract] [Hide abstract]
    ABSTRACT: We report a case of a 73-year-old woman with a brainstem stroke presenting as Wallenberg syndrome. By transoesophageal echocardiography and combined 18F-fluordeoxyglucose positron emission and CT (18F-FDG PET/CT), the diagnosis of large artery vasculitis owing to giant cell arteritis was confirmed. In the absence of classical clinical signs, the examination of the large extracranial vessels by ultrasound and 18F-FDG PET/CT played the key role in detecting a widespread vasculitis.
    Case Reports 03/2013; 2013. DOI:10.1136/bcr-2012-006994
Show more